Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(2.30)
# 2,637
Out of 4,955 analysts
387
Total ratings
38.66%
Success rate
-0.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $26.50 | +88.68% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.59 | +234.26% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $465.34 | +22.49% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $4.29 | +832.40% | 17 | Aug 4, 2025 | |
| ATAI Atai Life Sciences | Maintains: Buy | $10 → $15 | $4.40 | +240.91% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $3.51 | +184.90% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $0.52 | +859.14% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.54 | +1,739.25% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.43 | +1,281.22% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $32.67 | +206.09% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $15.54 | +350.45% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.00 | +400.00% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.70 | +1,176.60% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $20.89 | +282.96% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $12.64 | +216.46% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.40 | +783.65% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $37.40 | +87.17% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $15.99 | +400.31% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.71 | +484.80% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.16 | +362.96% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $9.63 | +471.13% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $4.41 | +2,394.33% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $43.00 | +97.67% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $6.79 | +2,110.76% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.68 | +436.49% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $170.90 | +98.95% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $26.50
Upside: +88.68%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $3.59
Upside: +234.26%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $465.34
Upside: +22.49%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $4.29
Upside: +832.40%
Atai Life Sciences
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.40
Upside: +240.91%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $3.51
Upside: +184.90%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $0.52
Upside: +859.14%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.54
Upside: +1,739.25%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $5.43
Upside: +1,281.22%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $32.67
Upside: +206.09%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $15.54
Upside: +350.45%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.00
Upside: +400.00%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.70
Upside: +1,176.60%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $20.89
Upside: +282.96%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $12.64
Upside: +216.46%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.40
Upside: +783.65%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $37.40
Upside: +87.17%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $15.99
Upside: +400.31%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.71
Upside: +484.80%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $2.16
Upside: +362.96%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $9.63
Upside: +471.13%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $4.41
Upside: +2,394.33%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $43.00
Upside: +97.67%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $6.79
Upside: +2,110.76%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.68
Upside: +436.49%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $170.90
Upside: +98.95%